Published in J Virol Methods on September 01, 1997
Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol (2003) 1.61
Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One (2009) 1.20
Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol (2005) 1.18
Detection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplification. J Clin Microbiol (2002) 1.06
Field study of dried blood spot specimens for HIV-1 drug resistance genotyping. J Clin Microbiol (2014) 0.87
Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens. J Clin Microbiol (2006) 0.85
Expanding access to HIV viral load testing: a systematic review of RNA stability in EDTA tubes and PPT beyond current time and temperature thresholds. PLoS One (2014) 0.79
Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell (1984) 5.56
Sexual transmission of hepatitis C virus. Lancet (1993) 4.27
Hepatitis C virus six years on. Lancet (1994) 4.09
Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet (1991) 3.97
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J (1984) 3.28
Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet (1993) 3.20
Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J (1985) 2.47
RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J Clin Microbiol (1996) 2.22
The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell (1986) 2.06
Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol (1994) 2.02
Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J Virol (1991) 1.83
Nucleotide sequence analysis of the nuclear gene coding for manganese superoxide dismutase of yeast mitochondria, a gene previously assumed to code for the Rieske iron-sulphur protein. Eur J Biochem (1985) 1.66
The duration of fixation influences the yield of HCV cDNA-PCR products from formalin-fixed, paraffin-embedded liver tissue. J Virol Methods (1994) 1.62
Cloned human snRNP proteins B and B' differ only in their carboxy-terminal part. EMBO J (1989) 1.59
Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood (1990) 1.59
Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol Pathol (1998) 1.48
International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods (1996) 1.41
New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion (1998) 1.39
New anti-human immunodeficiency virus immunoblot assays resolve nonspecific western blot results. Transfusion (1997) 1.38
Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol (1986) 1.37
Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines. J Gen Virol (1987) 1.36
Upstream regions of the hamster desmin and vimentin genes regulate expression during in vitro myogenesis. EMBO J (1987) 1.36
Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO J (1989) 1.35
Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol (1992) 1.33
Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol (1986) 1.33
Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probes. J Virol (1986) 1.24
Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. J Clin Microbiol (1999) 1.20
Subunit II of yeast QH2:cytochrome-c oxidoreductase. Nucleotide sequence of the gene and features of the protein. Eur J Biochem (1987) 1.16
Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus. Transfusion (1995) 1.15
The primary structure of leucine aminopeptidase from bovine eye lens. J Biol Chem (1982) 1.14
Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season. J Clin Microbiol (2006) 1.13
Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients. Transfusion (1993) 1.09
[Molecular genetic studies in alpha-thalassemia]. Ned Tijdschr Geneeskd (1992) 1.07
Detection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplification. J Clin Microbiol (2002) 1.06
Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol (1994) 1.04
Affinity purification of a major and a minor allergen from dog extract: serologic activity of affinity-purified Can f I and of Can f I-depleted extract. J Allergy Clin Immunol (1991) 1.04
Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification. J Virol Methods (1998) 1.03
Targeting efficiency of a mitochondrial pre-sequence is dependent on the passenger protein. EMBO J (1986) 1.02
Intermediate filament formation after transfection with modified hamster vimentin and desmin genes. J Cell Sci (1987) 1.01
A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals. J Clin Pathol (2000) 1.00
Genetic mapping of Pim-1 putative oncogene to mouse chromosome 17. Somat Cell Mol Genet (1986) 0.99
Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons. AIDS Res Hum Retroviruses (1998) 0.99
Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang (1992) 0.96
Risk of virus transmission by tissue, blood, and plasma products. Transplant Proc (1996) 0.95
Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection. Transfusion (1994) 0.93
Improved detection of rhinoviruses by nucleic acid sequence-based amplification after nucleotide sequence determination of the 5' noncoding regions of additional rhinovirus strains. J Clin Microbiol (2003) 0.92
Monoclonal antibodies to the major feline allergen Fel d I. I. Serologic and biologic activity of affinity-purified Fel d I and of Fel d I-depleted extract. J Allergy Clin Immunol (1988) 0.92
NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest (1992) 0.91
Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet (1995) 0.90
Increased production of nitric oxide correlates with viral load and activation of mononuclear phagocytes in HIV-infected patients. Scand J Infect Dis (1996) 0.90
Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAs. Vox Sang (1995) 0.90
Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. J Med Virol (1994) 0.90
Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products. Vox Sang (1997) 0.89
Skin tests and histamine release with P1-depleted Dermatophagoides pteronyssinus body extracts and purified P1. J Allergy Clin Immunol (1988) 0.89
Discrepancies between the skin test and IgE antibody assays: study of histamine release, complement activation in vitro, and occurrence of allergen-specific IgG. J Allergy Clin Immunol (1988) 0.88
Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding. Protein Eng (1998) 0.88
Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2B treatment in hemophilia patients. Scand J Gastroenterol (1992) 0.87
Characterization of the quantitative HCV NASBA assay. J Virol Methods (1999) 0.86
Deconjugation of glucuronides catalysed by UDPglucuronyltransferase. Biochim Biophys Acta (1986) 0.86
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations. AIDS Res Hum Retroviruses (2000) 0.86
Evaluation of a new HTLV-I/II polymerase chain reaction. Vox Sang (1997) 0.86
Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. J Med Virol (1997) 0.85
Assignment of the human homologue of Pim-1, a mouse gene implicated in leukemogenesis, to the pter-q12 region of chromosome 6. Hum Genet (1986) 0.85
Tissue-specific expression of a vimentin--desmin hybrid gene in transgenic mice. EMBO J (1988) 0.85
Variability of IgM response in hepatitis C virus infection. J Med Virol (1993) 0.84
Sensitivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodies. Transfusion (1996) 0.84
Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Transfusion (1997) 0.84
Implementation of HCV-NAT testing in The Netherlands. Dev Biol (Basel) (2000) 0.83
Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop. Arterioscler Thromb (1994) 0.83
Detection of hepatitis C viral RNA sequences in fresh and paraffin-embedded liver biopsy specimens of non-A, non-B hepatitis patients. J Hepatol (1992) 0.83
HBsAg-negative mono-infection with hepatitis B virus genotype G. J Viral Hepat (2010) 0.83
High prevalence of hepatitis G virus after liver transplantation without apparent influence on long-term graft function. J Hepatol (1997) 0.81
Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay. Transfusion (2010) 0.81
Development of a baculovirus vector that facilitates the generation of p10-based recombinants. J Virol Methods (1995) 0.81
Immunologic induction of malignant lymphoma: graft-vs-host reaction-induced B cell lymphomas contain integrations of predominantly ecotropic murine leukemia proviruses. J Immunol (1986) 0.81
Structure of the major cat allergen Fel d I in different allergen sources: an immunoblotting analysis with monoclonal antibodies against denatured Fel d I and human IgE. Int Arch Allergy Immunol (1992) 0.80
New immunoblot resolves indeterminate results for antibody to hepatitis C virus. Transfusion (1994) 0.80
Limited tryptic digestion of bovine eye lens leucine aminopeptidase. FEBS Lett (1979) 0.79
Surface antigen-negative hepatitis B virus infection in Dutch blood donors. Eur J Clin Microbiol Infect Dis (2013) 0.79
Confirmation of hepatitis C infection: a comparison of five immunoblot assays. Transfusion (1994) 0.79
Should the c100 antigen be removed from HCV antibody assays? Vox Sang (1994) 0.79
Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire. J Gen Virol (1998) 0.79
Microsomal conjugation and oxidation of bilirubin. Biochim Biophys Acta (1983) 0.79
Sensitivity of an anti-HCV core peptide ELISA. J Med Virol (1992) 0.78
Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol (1995) 0.78
Measurement of IgE on rat mast cells: relation to serum IgE and allergen-induced histamine release. Scand J Immunol (1983) 0.78
The stimulation of human peripheral blood lymphocytes by oral bacteria: macrophage and T-cell dependence. J Dent Res (1985) 0.77
UDP-glucuronyltransferase-catalyzed deconjugation of bilirubin monoglucuronide. Hepatology (1984) 0.77
Vernier zone residue 4 of mouse subgroup II kappa light chains is a critical determinant for antigen recognition. Immunotechnology (1999) 0.77
Detection of HIV-1 RNA in plasma by isothermal amplification (NASBA) irrespective of the stage of HIV-1 infection. J Virol Methods (1995) 0.77
A hybrid baculovirus-bacteriophage T7 transient expression system. Biotechnology (N Y) (1995) 0.77
Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history. Blood (1998) 0.77
IgG4 antibodies against pig-derived antigens. Am J Ind Med (1990) 0.77
Long term treatment of chronic hepatitis C with interferon alfa-2b: disappearance of HCV-RNA in a pilot study of eight haemophilia patients. Gut (1993) 0.75
The primary structure of bovine lens leucine aminopeptidase. Complete amino acid sequence of the N-terminal cyanogen bromide fragment and site of limited tryptic digestion. Biochem Biophys Res Commun (1980) 0.75